The global IV and oral iron drugs market is witnessing strong growth as healthcare providers increasingly adopt advanced iron replacement therapies for chronic anemia management. The market was valued at USD 8.65 billion in 2025 and is projected to grow from USD 9.62 billion in 2026 to USD 22.86 billion by 2034, registering a CAGR of 11.43% during the forecast period.
The rising prevalence of...
